Abstract: An abrasive blasting system that includes a blast hose; and a deadman assembly operably coupled therewith for controlling discharge out of the blast hose. The deadman assembly has a position of either a signal-flow or a no-flow position. When engaged to the signal-flow position, a burst or pulse of purge air is transferred to a mixer via a water injection conduit.

Abstract: In accordance with an embodiment, described herein is a system and method for deploying a service bus artifact from a local development environment to a service bus instance in a cloud environment. A deployment API can be plugged into the local development environment to perform a plurality of steps required for deploying the service bus artifact, including enabling communication from the local development environment to pass through a corporate firewall. The plurality of steps can be wrapped in a single service call to the service bus instance; and can include creating a session, uploading the service bus artifact, importing the uploaded service bus artifact, executing customization, and activating the session. In the event of a failure of any step, the service call can abort. The deployment API is generic and can be plugged into a plurality of development products.

Abstract: A method of selecting a real estate company using a computer-based network (100) to sell a property asset of a vendor or vendor representative, the method including the steps of obtaining information from the vendor or representative about the asset using information entry means (200) available from a server (104) in the computer-based network (100) and storing the information on the server (104); referring a plurality of agencies in the vicinity of the location of the property asset to be sold; enabling the referred agencies to assess the value of the asset; obtaining a tender submission from the referred agencies using tender submission entry means (600) available from the server (104) in the computer-based network (100); enabling the vendor or representative to review each tender submission; and the vendor or representative selecting an agency from the referred agencies to sell the asset based on the reviewed tender submissions.

Abstract: A method and device for counting the number of consecutive data symbols in a stream of data bytes, the device comprising a main counter for maintaining a count which is incremented/decremented for each respective consecutive data byte of said stream and adjustment means for incrementing/decrementing the count of the main counter, after every occurrence of a predetermined number of consecutive data bytes, by an adjustment value determined according to the ratio of the number of bits in the bytes to the number of bits in the symbols, such that the count represents a count of data symbols and a method and device for generating a synchronization signal from a received MPEG data stream with a MAC message containing an Upstream Slot Marker Pointer, the device including the above counting device, a controller for starting main counter according to a received MPEG synchronization signal and synchronization means for generating the synchronization signal once the main counter has counted the number of symbols indicate

Abstract: Compounds of formula (I) and their pharmaceutically acceptable salts are ligands at gastrin and/or cholecystokinin receptors. X and Y are independently ═N—, —N(R5)—═CH—, —S— or —O—.

Abstract: A layered exhaust gas catalyst containing Pt in a first layer and Rb in a second layer is more selective for catalyzing the reaction between NOx and/or nitrate with hydrocarbons and/or CO than for catalyzing the reaction between hydrocarbons and/or CO with oxygen. NOx can be reduced to N2 under constant lean to stoichiometric conditions without the need for rich spikes.

Abstract: Described herein are compounds of formula (I) or a pharmaceutically acceptable salt thereof, ##STR1## wherein L is N or C, one of X and Y is --NH--CH.sub.2 --R.sup.2 and the other is the substituent of formula (II). The compounds are potent gastrin and/or CCK antagonists.